30 ml ESPB ( n :30) | 20 ml ESPB ( n :30) | p | ||
---|---|---|---|---|
Age, year * | 51.40 ± 11,64 | 55.00 ± 9.45 | 0.194 | |
Gender δ | Female | 12 (40.0%) | 9 (30.0%) | 0.417 |
Male | 18 (60.0%) | 21 (70.0%) | ||
BMI β | 27.30 (23.30–28.50) | 26.50 (24.20–29) | 0.684 | |
Duration of Anesthesia (minute) β | 225 (210–270) | 225 (210–270) | 0.868 | |
ASA δ | I I | 12 (40.0%) | 15(50.0%) | 0.436 |
I I I | 18 (60.0%) | 15(50.0%) | ||
Intraoperative Remifentanil Consumption (mcg)* | 1049.17 ± 391.70 | 1013.33 ± 344.58 | 0.708 |